MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

dopamine

  • Home
  • dopamine
Dopamine-Enhancing Therapies in Age-Related Macular Degeneration: Assessing Risk Reduction for Neovascular Conversion
Posted innews Ophthalmology

Dopamine-Enhancing Therapies in Age-Related Macular Degeneration: Assessing Risk Reduction for Neovascular Conversion

Posted by By MedXY 06/25/2026
This study evaluates the association of dopamine-enhancing drugs, especially levodopa, with lowered 3-year risk of progression from non-neovascular to neovascular AMD, offering promising insight into dopaminergic pathways in AMD management.
Read More
The Hidden Battle in Our Brain: Why We Can’t Resist Hedonic Eating
Posted inFamily Medicine & Nutrition Medical News news Specialties

The Hidden Battle in Our Brain: Why We Can’t Resist Hedonic Eating

Posted by By MedXY 08/31/2025
Discover how dopamine neurons in the brain's reward center overpower satiety signals, driving hedonic eating even when we're full, revealing new insights for obesity treatment.
Read More
Three Minutes of ‘Small Talk’ That Keep Love Alive: How ‘Meaningless’ Chatter Boosts Dopamine and Deepens Bonds
Posted innews Psychiatry Specialties

Three Minutes of ‘Small Talk’ That Keep Love Alive: How ‘Meaningless’ Chatter Boosts Dopamine and Deepens Bonds

Posted by By MedXY 08/10/2025
Brief daily low-stakes exchanges—‘the clouds look like cotton candy’—build safety, activate reward circuits and sustain intimacy. Science explains why micro-connections matter and how clinicians and couples can use a 3‑minute practice to strengthen relationships.
Read More
  • Orbital and Periorbital Epithelioid Hemangioma: Clinical and Radiological Insights from a Multicentre Study of 25 Cases
  • Hearing Loss and Regional Brain Amyloid Deposition: Insights from In Vivo PET Imaging and Neuropathological Correlates
  • Optimizing Surgical Repair of Nasal Septal Perforations: Tailored Techniques and Risk Factor Management
  • Impact of Intraoperative Recurrent Laryngeal Nerve Monitoring on Post-Thyroidectomy Airway Outcomes: Insights from a Large National Cohort
  • Optimizing Ventriculoperitoneal Shunt Management During Emergency Abdominal Surgery: Evidence from a 25-Year Retrospective Cohort
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification semaglutide SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes weight loss

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top